Bridging Gaps for Radioligand Therapy: Policy Priorities for Scaled Implementation.
Abstract
![Figure][1] A popular saying in the nuclear medicine field is that our work spans “from bench to bedside.” But the path to get there isn’t always clear. Even though there are constant breakthroughs in research and development, the cutting-edge treatments offered by nuclear medicine don
Fields of Study & Subjects
Radiopharmaceutical Chemistry and Applications
Advances in Oncology and Radiotherapy
Health Systems
Economic Evaluations
Quality of Life
Publication details
- Journal / source
- PubMed
- Volume
- 67
- Issue
- 3
- Pages
- 4A–4A
- Publication date
- 2 March 2026
- Language
- EN